Publications in collaboration with researchers from Hospital Universitario Central de Asturias (14)

2022

  1. A Promising Antifungal and Antiamoebic Effect of Silver Nanorings, a Novel Type of AgNP

    Antibiotics, Vol. 11, Núm. 8

  2. Adherence of Candida albicans and Malassezia Species to Skin Cells Induces Changes in the Expression of Genes Responsible for Heparan and Chondroitin Sulfate Chain Synthesis

    Actas Dermo-Sifiliograficas, Vol. 113, Núm. 7, pp. 712-716

  3. Bacteria associated with acne use glycosaminoglycans as cell adhesion receptors and promote changes in the expression of the genes involved in their biosynthesis

    BMC Microbiology, Vol. 22, Núm. 1

  4. Cell Surface Glycosaminoglycans as Receptors for Adhesion of Candida spp. to Corneal Cells

    Polish Journal of Microbiology, Vol. 71, Núm. 1, pp. 55-62

2021

  1. Alterations in the Expression of the Genes Responsible for the Synthesis of Heparan Sulfate in Brains With Alzheimer Disease

    Journal of neuropathology and experimental neurology, Vol. 80, Núm. 5, pp. 446-456

  2. Glycosaminoglycans Are Involved in the Adhesion of Candida albicans and Malassezia Species to Keratinocytes But Not to Dermal Fibroblasts

    Actas Dermo-Sifiliograficas, Vol. 112, Núm. 7, pp. 619-624

  3. Heparan sulfate proteoglycans as possible diagnostic molecular tools with therapeutic potential in Alzheimeŕs disease

    Neural Regeneration Research

  4. The genes encoding small leucine-rich proteoglycans undergo differential expression alterations in colorectal cancer, depending on tumor location

    Cells, Vol. 10, Núm. 8

2020

  1. Adherence of Lactobacillus salivarius to HeLa Cells Promotes Changes in the Expression of the Genes Involved in Biosynthesis of Their Ligands

    Frontiers in Immunology, Vol. 10

  2. Antibacterial effect of silver nanorings

    BMC Microbiology, Vol. 20, Núm. 1

  3. Heparan sulfate proteoglycans undergo differential expression alterations in alzheimer disease brains

    Journal of Neuropathology and Experimental Neurology, Vol. 79, Núm. 5, pp. 474-483

2019

  1. Glycosaminoglycans are differentially involved in bacterial binding to healthy and cystic fibrosis lung cells

    Journal of Cystic Fibrosis, Vol. 18, Núm. 3, pp. e19-e25

2017

  1. Heparan sulfate proteoglycans and heparanases in Alzheimer’s disease: Current outlook and potential therapeutic targets

    Neural Regeneration Research

  2. Upregulated Expression of Heparanase and Heparanase 2 in the Brains of Alzheimer's Disease

    Journal of Alzheimer's Disease, Vol. 58, Núm. 1, pp. 185-192